Schedule 13G ownership disclosure

TITAN PHARMACEUTICALS INC D COM

Security class unavailable · CUSIP: 888314507

Event date: 2019-10-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,333,333
Percent of class
6.3200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-19-004033
Form type
SC 13G
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Oct 22, 2019
Reporting period
Oct 16, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub